弥合药理动力学和药理动力学:一个PBPK/PD基于模型的方法,用于在输血依赖的沙拉西米亚中使用德费拉西洛克斯剂量
Watchara Sakares1, Udomsak Udomnilobol2, Xian Pan3
1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Clinical and translational science
|September 18, 2025
概括
这项研究开发了一个模型,以个性化Deferasirox (DFX) 剂量用于输血依赖性沙拉西米亚 (TDT) 患者. 基于铁含量和输血的个性化DFX治疗改善了铁化疗法的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 生物医学工程 生物医学工程
背景情况:
- 输血依赖性血病 (TDT) 需要终身输血,导致铁过载.
- 有效的铁化疗法,主要是Deferasirox (DFX),对于TDT管理至关重要.
- 在DFX响应的个体变化突出需要了解药理动力学 (PK) 和药理动力学 (PD) 的因素.
研究的目的:
- 为DFX开发一个基于生理学的药理动力学-药理动力学 (PBPK/PD) 模型.
- 将肝脏和输血铁负担纳入DFX PBPK/PD模型.
- 根据铁含量和输血方案,优化TDT患者的DFX剂量策略.
主要方法:
- 开发了DFX的PBPK/PD模型,使用来自不同人群的临床PK数据.
- 将TDT特定的生理参数纳入模型.
- 验证了模型对DFX剂量要求的预测准确性,以实现肝脏铁度 (LIC) 的25%降低.
主要成果:
- 该PBPK/PD模型准确地预测了整个人群的DFX PK,并确定了铁水平对DFX清除的影响.
- 模拟显示较高的基线LIC与实现向的铁减少相关.
- 较低的基线LIC需要更高的DFX剂量,因为铁的调动速度较慢;减少输血改善了结果.
结论:
- 开发的PBPK/PD模型有效地预测了DFX剂量,以实现目标LIC减少.
- 个性化DFX剂量策略,考虑到基线铁负荷和输血模式,对于最大限度地提高TDT治疗结果至关重要.
- 这种方法支持TDT患者个性化铁化疗法.
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
278
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
278
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
215
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
215
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
01:26Pharmacokinetic Models: Comparison and Selection Criterion
338
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
338
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
222
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
222